...
首页> 外文期刊>Biotechnology Progress >Selective Cytotoxicity and Modulation of Apoptotic Signature of Breast Cancer Cells by Pithecellobium dulce Leaf Extracts
【24h】

Selective Cytotoxicity and Modulation of Apoptotic Signature of Breast Cancer Cells by Pithecellobium dulce Leaf Extracts

机译:皮氏梭菌叶提取物对乳腺癌细胞的选择性细胞毒性作用和对凋​​亡信号的调控

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report the potent and selective cytotoxicity of the crude aqueous leaf extract from the medicinal plant, Pithecellobium dulce toward the human breast cancer cells (MCF-7), but not the normal cells (MCF-10A). The cytotoxicity was found to be dose and time dependent, as 300 mu g/mL of the extract decreased the cell viability to 50% (IC50) in 48 h. The induction of apoptosis in the breast cancer cells after treatment was confirmed by significant percentage (24.7%), of early apoptotic cells (AnnexinV (+)Propidium Iodide-) in treated cells as compared to control cells (3.5%). We observed a significant upregulation in the mRNA expression of various pro-apoptotic gene such as Bax (21.1 folds), p21(14.4 folds), p53 (11.7 folds), TNF (10.2 folds) and fas (6.3 folds) after treatment as compared to untreated cells. On the other hand, the relative mRNA expression of anti-apoptotic genes such as Bcl-2, NF-KB and Cdk was reduced. The selective upregulation of pro-apoptotic gene and down regulation of specific anti-apoptotic genes could be the inducing factor for apoptotic cell death in MCF-7 cells after treatment with the herbal extract. We believe that our findings provide a foundation for further studies on this formulation as a potential therapeutic candidate for breast cancer. (C) 2016 American Institute of Chemical Engineers Biotechnol.
机译:我们报告了从药用植物Pithecellobium dulce对人乳腺癌细胞(MCF-7)而非正常细胞(MCF-10A)的粗叶提取物的强效和选择性细胞毒性。发现细胞毒性与剂量和时间有关,因为提取物300μg / mL在48小时内将细胞活力降低至50%(IC50)。与处理后的细胞(3.5%)相比,处理后的乳腺癌细胞中的早期凋亡细胞(AnnexinV(+)碘化丙啶-)的显着百分比(24.7%)证实了乳腺癌细胞治疗后的诱导凋亡。我们观察到治疗后各种促凋亡基因如Bax(21.1倍),p21(14.4倍),p53(11.7倍),TNF(10.2倍)和fas(6.3倍)的mRNA表达显着上调到未经处理的细胞。另一方面,抗凋亡基因例如Bcl-2,NF-KB和Cdk的相对mRNA表达降低。草药提取物处理后,促凋亡基因的选择性上调和特定抗凋亡基因的下调可能是MCF-7细胞凋亡的原因。我们相信,我们的发现为该制剂作为潜在的乳腺癌治疗药物的进一步研究奠定了基础。 (C)2016美国化学工程师学会生物技术研究所。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号